Clinical Trial Update: Aromatase Inhibitors in the Treatment of Male Infertility [Phase 3]

View source ↗

Summary

Phase 3 trial of aromatase inhibitors for male infertility was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Male Infertility
• Obesity
• Oligospermia

Drugs mentioned

• Aromatase inhibitor (Aromatase inhibitor)

Snippet

Sponsor: University of Utah | Conditions: Obesity, Oligospermia | Phase 3 | Status: TERMINATED | Results posted: 2016-03-07